Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies for Patients with COPD and Phenotypic Features of Asthma: A Pooled Post Hoc Analysis of KRONOS and ETHOS

Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies for Patients with COPD and Phenotypic Features of Asthma: A Pooled Post Hoc Analysis of KRONOS and ETHOS

Shigeo Muro,1 Munehiro Seki,2 John R Hurst,3 David Petullo,4 Jonathan Marshall,5 Karin Bowen,4 Patrick F Darken,4 Elizabeth A Duncan,6 Ayman Megally,4 Mehul Patel5 1Department of Respiratory Medicine, Nara Medical University, Nara, Japan; 2AstraZeneca K.K., Osaka, Japan; 3UCL Respiratory, University...

Full description

Saved in:
Bibliographic Details
Main Authors: Muro S, Seki M, Hurst JR, Petullo D, Marshall J, Bowen K, Darken PF, Duncan EA, Megally A, Patel M
Format: Article
Language:English
Published: Dove Medical Press 2024-12-01
Series:International Journal of COPD
Subjects:
asthma
budesonide/glycopyrronium/formoterol fumarate dihydrate
chronic obstructive pulmonary disease
copd
exacerbation
health-related quality of life
lung function
Online Access:https://www.dovepress.com/triple-therapy-with-budesonideglycopyrroniumformoterol-fumarate-dihydr-peer-reviewed-fulltext-article-COPD
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/triple-therapy-with-budesonideglycopyrroniumformoterol-fumarate-dihydr-peer-reviewed-fulltext-article-COPD

Similar Items